title: [Analysis of therapeutic compliance in women with osteoporosis].
abstract: OBJECTIVE
  To assess therapeutic compliance in osteoporosis in women in a Primary Care (PC) setting.
  
  
  METHODS
  Observational, descriptive, cross-sectional and multicenter study, conducted in PC centers of the 17 Spanish Autonomous Regions. 1,649 women who had initiated treatment for osteoporosis at least 3 months before entering the study were recruited. To assess therapeutic compliance, two questionnaires, the Haynes-Sackett or self-communicated compliance test (AC) and the Morisky-Green test (MG) were used.
  
  
  RESULTS
  Patients' mean age (± SD) was 66.59 years (9.5) and the mean time since diagnosis was 5.08 years (4.87). Bisphosphonates were the most precribed drugs (82% of the patients) and only 52% of the patients were taking calcium and vitamin D supplements. Analysis of the therapeutic compliance level shows that, as per the MG test, 68.7% of the patients were non-compliers, and 11.2% were non-compliers as per the AC test.
  
  
  CONCLUSIONS
  An important percentage of women with post-menopausal osteoporosis in Spain's PC setting show a high level of non-compliance.
authors.affiliation: Centro de Salud Vía Roma, Universidad de Barcelona, Barcelona, España. ccarbonella@medynet.com
authors.forename: Cristina
authors.initials: C
authors.lastname: Carbonell Abella
authors.forename: Nuria
authors.initials: N
authors.lastname: Guañabens Gay
authors.forename: Lucía
authors.initials: L
authors.lastname: Regadera Anechina
authors.forename: José Antonio
authors.initials: JA
authors.lastname: Marín Rives
authors.forename: Elena
authors.initials: E
authors.lastname: Taverna Llauradó
authors.forename: Manuel Pedro
authors.initials: MP
authors.lastname: Ayechu Redín
mesh_terms: D000368:Aged; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002118:Calcium / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D004164:Diphosphonates / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D011320:Primary Health Care; D011795:Surveys and Questionnaires; D014807:Vitamin D / Q000627:therapeutic use; D016903:Drug Monitoring
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D014807:Vitamin D; D002118:Calcium